Nanofibrous Vildagliptin-Eluting Stents Enhance Re-Endothelialization And Reduce Neointimal Formation In Diabetes: In Vitro And In Vivo [Corrigendum]

Lee CH, Hsieh MJ, Chang SH, et al. Int J Nano. 2019;14:7503–7513. The authors noticed a mistake in the published paper which was overlooked during the revision stages. On page 7511, in the Acknowledgments section, the sentence “… Chang Gung M...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Lee CH, Hsieh MJ, Chang SH, Hung KC, Wang CJ, Hsu MY, Juang JH, Hsieh IC, Wen MS, Liu SJ
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/4362d81c770a46c4901c73455604f282
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:4362d81c770a46c4901c73455604f282
record_format	dspace
spelling	oai:doaj.org-article:4362d81c770a46c4901c73455604f2822021-12-02T11:16:10ZNanofibrous Vildagliptin-Eluting Stents Enhance Re-Endothelialization And Reduce Neointimal Formation In Diabetes: In Vitro And In Vivo [Corrigendum]1178-2013https://doaj.org/article/4362d81c770a46c4901c73455604f2822019-12-01T00:00:00Zhttps://www.dovepress.com/httpswwwdovepresscomcorrigendum-nanofibrous-vildagliptin-eluting-stent-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Lee CH, Hsieh MJ, Chang SH, et al. Int J Nano. 2019;14:7503–7513. The authors noticed a mistake in the published paper which was overlooked during the revision stages. On page 7511, in the Acknowledgments section, the sentence “… Chang Gung Memorial Hospital (Contract No. CMRPG3G1291) for financially supporting this research.” should read “… Chang Gung Memorial Hospital (Contract No. CMRPG3G1291 and CMRPG3G1292) for financially supporting this research.” The authors apologize for this oversight.Read the original articleLee CHHsieh MJChang SHHung KCWang CJHsu MYJuang JHHsieh ICWen MSLiu SJDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 14, Pp 9793-9794 (2019)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine (General) R5-920
spellingShingle	Medicine (General) R5-920 Lee CH Hsieh MJ Chang SH Hung KC Wang CJ Hsu MY Juang JH Hsieh IC Wen MS Liu SJ Nanofibrous Vildagliptin-Eluting Stents Enhance Re-Endothelialization And Reduce Neointimal Formation In Diabetes: In Vitro And In Vivo [Corrigendum]
description	Lee CH, Hsieh MJ, Chang SH, et al. Int J Nano. 2019;14:7503–7513. The authors noticed a mistake in the published paper which was overlooked during the revision stages. On page 7511, in the Acknowledgments section, the sentence “… Chang Gung Memorial Hospital (Contract No. CMRPG3G1291) for financially supporting this research.” should read “… Chang Gung Memorial Hospital (Contract No. CMRPG3G1291 and CMRPG3G1292) for financially supporting this research.” The authors apologize for this oversight.Read the original article
format	article
author	Lee CH Hsieh MJ Chang SH Hung KC Wang CJ Hsu MY Juang JH Hsieh IC Wen MS Liu SJ
author_facet	Lee CH Hsieh MJ Chang SH Hung KC Wang CJ Hsu MY Juang JH Hsieh IC Wen MS Liu SJ
author_sort	Lee CH
title	Nanofibrous Vildagliptin-Eluting Stents Enhance Re-Endothelialization And Reduce Neointimal Formation In Diabetes: In Vitro And In Vivo [Corrigendum]
title_short	Nanofibrous Vildagliptin-Eluting Stents Enhance Re-Endothelialization And Reduce Neointimal Formation In Diabetes: In Vitro And In Vivo [Corrigendum]
title_full	Nanofibrous Vildagliptin-Eluting Stents Enhance Re-Endothelialization And Reduce Neointimal Formation In Diabetes: In Vitro And In Vivo [Corrigendum]
title_fullStr	Nanofibrous Vildagliptin-Eluting Stents Enhance Re-Endothelialization And Reduce Neointimal Formation In Diabetes: In Vitro And In Vivo [Corrigendum]
title_full_unstemmed	Nanofibrous Vildagliptin-Eluting Stents Enhance Re-Endothelialization And Reduce Neointimal Formation In Diabetes: In Vitro And In Vivo [Corrigendum]
title_sort	nanofibrous vildagliptin-eluting stents enhance re-endothelialization and reduce neointimal formation in diabetes: in vitro and in vivo [corrigendum]
publisher	Dove Medical Press
publishDate	2019
url	https://doaj.org/article/4362d81c770a46c4901c73455604f282
work_keys_str_mv	AT leech nanofibrousvildagliptinelutingstentsenhancereendothelializationandreduceneointimalformationindiabetesinvitroandinvivocorrigendum AT hsiehmj nanofibrousvildagliptinelutingstentsenhancereendothelializationandreduceneointimalformationindiabetesinvitroandinvivocorrigendum AT changsh nanofibrousvildagliptinelutingstentsenhancereendothelializationandreduceneointimalformationindiabetesinvitroandinvivocorrigendum AT hungkc nanofibrousvildagliptinelutingstentsenhancereendothelializationandreduceneointimalformationindiabetesinvitroandinvivocorrigendum AT wangcj nanofibrousvildagliptinelutingstentsenhancereendothelializationandreduceneointimalformationindiabetesinvitroandinvivocorrigendum AT hsumy nanofibrousvildagliptinelutingstentsenhancereendothelializationandreduceneointimalformationindiabetesinvitroandinvivocorrigendum AT juangjh nanofibrousvildagliptinelutingstentsenhancereendothelializationandreduceneointimalformationindiabetesinvitroandinvivocorrigendum AT hsiehic nanofibrousvildagliptinelutingstentsenhancereendothelializationandreduceneointimalformationindiabetesinvitroandinvivocorrigendum AT wenms nanofibrousvildagliptinelutingstentsenhancereendothelializationandreduceneointimalformationindiabetesinvitroandinvivocorrigendum AT liusj nanofibrousvildagliptinelutingstentsenhancereendothelializationandreduceneointimalformationindiabetesinvitroandinvivocorrigendum
_version_	1718396045287751680

Nanofibrous Vildagliptin-Eluting Stents Enhance Re-Endothelialization And Reduce Neointimal Formation In Diabetes: In Vitro And In Vivo [Corrigendum]

Ejemplares similares